Brief: Aileron Therapeutics Presents Data Demonstrating Alrn-6924’S Activity As Radioprotective Agent In Preclinical Models Of Acute Radiation-Induced Toxicity
07/10/2021 14:26
Oct 7 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* AILERON THERAPEUTICS PRESENTS DATA AT AACR-NCI-EORTC
INTERNATIONAL CONFERENCE DEMONSTRATING ALRN-6924’S ACTIVITY AS
RADIOPROTECTIVE AGENT IN PRECLINICAL MODELS OF ACUTE
RADIATION-INDUCED TOXICITY
* AILERON THERAPEUTICS INC - NEW PRECLINICAL FINDINGS
SUPPORT
FURTHER STUDY OF ALRN-6924 AS A POTENTIAL RADIOPROTECTIVE AGENT
Source text for Eikon: ID:nGNXf7sD4
Further company coverage: ALRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering